Amyloid plaques are still main target for Alzheimer's drugs

BMJ. 2016 Jan 13:352:i214. doi: 10.1136/bmj.i214.
No abstract available

Publication types

  • News

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Clinical Trials as Topic
  • Disease Progression
  • Humans
  • Plaque, Amyloid / drug therapy*

Substances

  • Antibodies, Monoclonal, Humanized
  • aducanumab
  • solanezumab